Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Scott (Tarrytown, United States of America), J. Allinne (Tarrytown, United States of America), S. Asrat (Tarrytown, United States of America), W. Lim (Tarrytown, United States of America), K. Nagashima (Tarrytown, United States of America), D. Birchard (Tarrytown, United States of America), S. Srivatsan (Tarrytown, United States of America), D. Ajithdoss (Tarrytown, United States of America), A. Oyejide (Tarrytown, United States of America), L. Ben (Tarrytown, United States of America), J. Walls (Tarrytown, United States of America), A. Le Floc'H (Tarrytown, United States of America), G. Yancopoulos (Tarrytown, United States of America), A. Murphy (Tarrytown, United States of America), M. Sleeman (Tarrytown, United States of America), J. Orengo (Tarrytown, United States of America). Comparison of transcriptional differences between IL-4Ra and IL-5 blockade in a mouse model of asthma. 674

Member's Comments

No comment yet.

Related content which might interest you: Correlation of eotaxin-3 gene expression and other IL-13-induced genes in patients with asthma Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man Year: 2021 Transgenic mice overexpressing IL-18 display increased IL-13 in the airways but no changes of the airway hyperresponsiveness in a murine model of late-phase asthma: evidence for a dual role of IL-18 on mucosal Th1/Th2 responses Source: Eur Respir J 2002; 20: Suppl. 38, 1s Year: 2002 The expression of IL17RA (the common subunit of IL-17A and IL-25 receptor) on sputum macrophages in asthma patients Source: Virtual Congress 2021 – Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD Year: 2021 Local inhibition of IL-4 and IL-13 protects lung function in OVA mouse model Source: Annual Congress 2011 - Animal models of airway inflammation Year: 2011 Interleukin (IL-13) modulates allergen-induced airway hyperresponsiveness by a pathway independent of IL-5 or eotaxin in mice Source: Eur Respir J 2003; 22: Suppl. 45, 194s Year: 2003 PARP-1 deficiency blocks IL-5 expression through calpain-dependent degradation of STAT-6 in a murine asthma model Source: Annual Congress 2011 - Animal models of airway inflammation Year: 2011 LSC - 2019 - IL-4, IL-8, IL-13, IL-17, IL-33 serum levels changes in acute allergic asthma model Source: International Congress 2019 – Novel insights from in vitro and in vivo models of lung disease Year: 2019 Investigations on the role of region-specific IL-13 receptor alpha 1 expression along the airway tree in mucus production in asthma Source: Annual Congress 2012 - Mechanistic studies in airway cell biology Year: 2012 Differential gene expression and cytokine production from neutrophils in asthma phenotypes Source: Eur Respir J 2010; 35: 522-531 Year: 2010 Polymorphisms of the IL-4 and IL-4 receptor alpha chain genes and bronchial asthma Source: Eur Respir J 2005; 26: Suppl. 49, 708s Year: 2005 A dual role of IL-6 signalling and STAT-3 activation on airway inflammation versus airway hyperresponsiveness in a murine model of asthma Source: Eur Respir J 2002; 20: Suppl. 38, 568s Year: 2002 Blocking IL-4Ra with dupilumab prevents lung inflammation in a mouse asthma model Source: International Congress 2018 – Identification of therapeutic targets for asthma Year: 2018 IL-33 augments rhinovirus-induced type 2 immune responses in asthma via selective upregulation of one chain of the IL-33 receptor. Source: International Congress 2017 – "Alarming" immunological patterns in asthma Year: 2017 Decreased Smad7 expression in the airways of a mouse model of chronic asthma Source: Annual Congress 2004 - Animal models of allergic airway disease Year: 2004 Up-regulation of arginase in rat primary airway fibroblasts by IL-4 and IL-13 Source: Eur Respir J 2003; 22: Suppl. 45, 386s Year: 2003 Correlation of the interleukin-5 level in sputum and serum in asthma patients with the different polymorphism by C703-T (IL-5 gene) Source: Eur Respir J 2001; 18: Suppl. 33, 371s Year: 2001 IL-9 and IL-9 receptor (IL-9r) expression in BALF lymphocytes in ILD patients: preliminary results. Source: International Congress 2017 – The wide spectrum of ILDs Year: 2017 AZD1402/PRS-060, an inhaled Anticalin® IL-4Ra antagonist, potently inhibits IL-4 induced functional effects in human whole blood, which can be employed translationally in clinical studies. Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control Year: 2018 The expression of interleukin-13 gene is regulated by nfat1 in human T cells Source: Annual Congress 2005 - Regulation of the allergic and asthmatic response Year: 2005